Global Triage B-Type Natriuretic Peptide (BNP) Testing Market – Industry Trends and Forecast to 2027

  • Healthcare
  • Upcoming Report
  • Feb 2020
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

Global Triage B-Type Natriuretic Peptide (BNP) Testing Market By Application (Acute Myocardial Infarction (AMI), Acute Coronary Syndrome (ACS), Congestive Heart Failure (CHF), Others), End-Use (Laboratory Testing, Point of Care Testing), Country ((U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa), Market Trends and  Forecast to 2027

Triage B-Type Natriuretic Peptide (BNP) Testing Market

Market Analysis and Insights of Global Triage B-Type Natriuretic Peptide (BNP) Testing Market

Triage B-type natriuretic peptide (BNP) testing market is expected to gain market growth in the forecast period of 2020 to 2027. Data Bridge Market Research analyses the market to grow at a CAGR of 3.20% in the above-mentioned forecast period.  

B-type natriuretic peptide, also known as the brain natriuretic peptide, is a 32-amino acid (AA) polypeptide formed by cardiac ventricles as a reflex action to overstretch cardiac muscle cells. BNP generation is regulated by calcium ions. BNP and ANP (atrial natriuretic peptide) work in a similar way and the biochemical activity of both is identical. The important function of ANP and BNP is to minimize systemic vascular resistance, which contributes to a reduction in blood volume, resulting in a decline in blood pressure and an improvement in cardiac output.

BNP testing is one of the most significant diagnostic tests used to treat cardiovascular disease. The main function of BNP screening is the prevention of cardiovascular diseases, such as cardiac arrest and cardiac failure. For addition, a spike for BNP (more than 100 pg / ml) suggests signs of recurrent heart disease, such as cardiac failure. This increased value demonstrates the chronic medical condition known as left ventricular dysfunction. Measurements were made utilizing immunoassay techniques. In contrast, BNP levels increase during renal failure, but it is not advised to check for renal failure due to large variations in performance.

Growing incidence of cardiac diseases, rising awareness about diagnostics and increasing demand for effectual cardiac disease diagnostic test are some of the major factors expected to drive the growth of triage B-type natriuretic peptide (BNP) testing market in the forecast period of 2020 to 2027.

This triage B-type natriuretic peptide (BNP) testing market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on triage B-type natriuretic peptide (BNP) testing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth. 

Global Triage B-type Natriuretic Peptide (BNP) Testing Market Scope and Market Size

Triage B-type natriuretic peptide (BNP) testing market is segmented on the basis of application and end use. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • Based on application, the triage B-type natriuretic peptide (BNP) testing market is segmented into acute myocardial infarction (AMI), acute coronary syndrome (ACS), congestive heart failure (CHF) and others.
  • On the basis of end use, the triage B-type natriuretic peptide (BNP) testing market has been segmented into laboratory testing and point of care testing.

Triage B-type Natriuretic Peptide (BNP) Testing Market Country Level Analysis

Global triage B-type natriuretic peptide (BNP) testing market is analysed and market size information is provided by country, application and end use as referenced above.

The countries covered in the market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific in the Asia-Pacific, Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa as a part of Middle East & Africa, Brazil, Argentina and Rest of South America as part of South America.

The country section of the triage B-type natriuretic peptide (BNP) testing market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure Growth Installed Base and New Technology Penetration

Triage B-type natriuretic peptide (BNP) testing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for triage B-type natriuretic peptide (BNP) testing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the triage B-type natriuretic peptide (BNP) testing market. The data is available for historic period 2010 to 2018.

Competitive Landscape and Triage B-type Natriuretic Peptide (BNP) Testing Market Share Analysis

Triage B-type natriuretic peptide (BNP) testing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to triage B-type natriuretic peptide (BNP) testing market.

The major players covered in the report are Abbott, BD, Beckman Coulter, Inc., F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories, Inc., BG Medicine, Inc., bioMérieux SA, Thermo Fisher Scientific Inc., Siemens Healthcare Private Limited and Randox Laboratories Ltd among other domestic and global players. Market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Customization Available: Global Triage B-Type Natriuretic Peptide (BNP) Testing Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

Please fill in the below form for detailed List of Table

Please fill in the below form for detailed List of Figure

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
BUY NOW ADD TO CART
Why Choose Us
REQUEST FOR SAMPLE